029-83533393
   info@TaiBSbio.com
 
组织芯片，组织微阵列
多器官
头颈部
口腔
软组织(肌肉脂肪血管等)
皮肤
黑色素瘤
淋巴瘤
脑
心脏
鼻咽和喉
肺
骨和软骨
骨髓
食道
胃
小肠
结肠
直肠
肝
胰腺
阑尾
肾脏
尿道膀胱
甲状腺
肾上腺
胸腺
淋巴结
脾
乳腺
卵巢
输卵管
子宫及内膜
子宫颈
外阴 (阴唇)
前列腺
睾丸
阴茎
间皮
转移癌
胚胎瘤
胎儿
寄生虫
猴子 -恒河猴
猴子 -食蟹猴,
狗
大鼠
小鼠
其它
免疫系统
 
FOV803b卵巢癌组织芯片，附病理分级、TNM和临床分期，80例/80点，替代OV803a
点 数80例 数80
行 数8列 数10
点直径(mm)1.5厚度(µm)5.0
组织阵列类型石蜡包埋种 属人类
QA/QCH&E and IHC confirmed
ApplicationsRoutine histology procedures including Immunohistochemistry (IHC) and In Situ Hybridization (ISH), protocols which can be found at our support page.
Notes1.Please keep the slides at 4 ℃ after receiving, and make experiment within 3 months will be better.

2.Bake the slides for 30 minutes at 60℃ before the experiment;

3.Please choose a gentle repair method to avoid tissue detachment.
产品名:FOV803b
 
卵巢腺癌组织微阵列芯片，包含腺癌79例，透明细胞癌1例，每例取一点
 
 
询价  Tel: 029-83533393
 
下载说明书
 
 
Legend:
Ova
-Ovary
 
Malignant (I)
 
Malignant (IA)
 
Malignant (IB)
 
Malignant (IC)
 
Malignant (II)
 
Malignant (IIA)
 
Malignant (IIB)
 
Malignant (III)
 
Malignant (IIIC)
 
Malignant (IV)
TISSUE  ARRAYS FOV803b
1
2
3
4
5
6
7
8
9
10
A
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
B
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
C
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
D
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
E
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
F
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
G
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
H
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
 
PosNoAgeSexOrgan_Anatomic_SitePathology_diagnosisGradeTNMStageTypeisBackUp
A1134FOvarySerous papillary adenocarcinoma1T1bN0M0IBMalignantN
A2242FOvarySerous adenocarcinoma2T1N0M0IMalignantN
A3359FOvarySerous papillary adenocarcinoma1T1aN0M0IAMalignantN
A4448FOvarySerous papillary adenocarcinoma with necrosis1T1N0M0IMalignantN
A5538FOvarySerous papillary adenocarcinoma1T3cN1M1IVMalignantN
A6647FOvarySerous papillary adenocarcinoma1T1aN0M0IAMalignantN
A7725FOvarySerous papillary adenocarcinoma1T1N0M0IMalignantN
A8851FOvarySerous papillary adenocarcinoma with degeneration1T3cN1M0IIICMalignantN
A9957FOvarySerous adenocarcinoma1T1cN0M0ICMalignantN
A101053FOvarySerous adenocarcinoma2T1aN0M0IAMalignantN
B11161FOvarySerous papillary adenocarcinoma1T1bN0M0IBMalignantN
B21260FOvarySerous papillary adenocarcinoma1T1bN0M0IBMalignantN
B31332FOvarySerous papillary adenocarcinoma1T1N0M0IMalignantN
B41453FOvarySerous adenocarcinoma1T1N0M0IMalignantN
B51533FOvarySerous adenocarcinoma1T1N0M0IMalignantN
B61650FOvarySerous papillary adenocarcinoma1T2aN0M0IIAMalignantN
B71722FOvarySerous papillary adenocarcinoma1T2bN0M0IIBMalignantN
B81864FOvarySerous adenocarcinoma with necrosis2T3N1M1IVMalignantN
B91926FOvarySerous papillary adenocarcinoma1T3cN1M0IIICMalignantN
B102056FOvarySerous adenocarcinoma1T2N0M0IIMalignantN
C12148FOvarySerous adenocarcinoma2T1bN0M0IBMalignantN
C22235FOvarySerous adenocarcinoma2T1aN0M0IAMalignantN
C32352FOvarySerous adenocarcinoma2T1aN0M0IAMalignantN
C42459FOvarySerous adenocarcinoma2T1cN0M0ICMalignantN
C52568FOvarySerous adenocarcinoma2T1aN0M0IAMalignantN
C62646FOvarySerous adenocarcinoma2T1aN0M0IAMalignantN
C72749FOvarySerous adenocarcinoma2T3cN0M0IIICMalignantN
C82853FOvarySerous papillary adenocarcinoma1T2N0M1IVMalignantN
C92952FOvarySerous adenocarcinoma2T2N0M0IIMalignantN
C103051FOvarySerous adenocarcinoma2T1cN0M0ICMalignantN
D13154FOvarySerous adenocarcinoma2T2bN0M0IIBMalignantN
D23256FOvarySerous adenocarcinoma2T3cN1M1IVMalignantN
D33354FOvarySerous adenocarcinoma with necrosis2T3cN1M0IIICMalignantN
D43451FOvarySerous adenocarcinoma2T1aN0M0IAMalignantN
D53560FOvarySerous papillary adenocarcinoma1T2aN0M0IIAMalignantN
D63651FOvarySerous adenocarcinoma1T3N1M0IIICMalignantN
D73773FOvarySerous adenocarcinoma2T2aN0M0IIAMalignantN
D83838FOvarySerous adenocarcinoma3T3bN1M0IIICMalignantN
D93947FOvarySerous adenocarcinoma2T1aN0M0IAMalignantN
D104058FOvarySerous adenocarcinoma with necrosis3T1N0M0IMalignantN
E14141FOvarySerous adenocarcinoma3T1N0M0IMalignantN
E24250FOvarySerous adenocarcinoma3T1N0M0IMalignantN
E34349FOvarySerous papillary adenocarcinoma3T2N0M0IIMalignantN
E44452FOvarySerous adenocarcinoma3T1cN0M0ICMalignantN
E54546FOvarySerous adenocarcinoma3T3aN1M0IIICMalignantN
E64646FOvarySerous adenocarcinoma3T2cN1M0IIICMalignantN
E74757FOvarySerous adenocarcinoma3T3cN1M0IIICMalignantN
E84852FOvarySerous adenocarcinoma with necrosis3T2N0M0IIMalignantN
E94975FOvarySerous adenocarcinoma3T2N0M0IIMalignantN
E105054FOvarySerous adenocarcinoma with degeneration3T1bN0M0IBMalignantN
F15166FOvarySerous adenocarcinoma with necrosis3T3N1M0IIICMalignantN
F25249FOvarySerous adenocarcinoma3T3N1M0IIICMalignantN
F35354FOvarySerous adenocarcinoma with necrosis3T3cN1M0IIICMalignantN
F45442FOvarySerous adenocarcinoma3T3cN1M0IIICMalignantN
F55560FOvarySerous adenocarcinoma3T1aN0M0IAMalignantN
F65647FOvarySerous adenocarcinoma3T2aN0M0IIAMalignantN
F75756FOvarySerous adenocarcinoma3T3N1M0IIICMalignantN
F85847FOvarySerous adenocarcinoma3T1cN0M0ICMalignantN
F95972FOvarySerous adenocarcinoma-T1aN0M0IAMalignantN
F106055FOvarySerous adenocarcinoma (sparse)3T2N0M0IIMalignantN
G16149FOvarySerous adenocarcinoma3T2N0M0IIMalignantN
G26232FOvarySerous adenocarcinoma3T3cN0M0IIICMalignantN
G36360FOvarySerous adenocarcinoma3T1bN0M0IBMalignantN
G46445FOvaryMucinous cystadenocarcinoma1T1aN0M0IAMalignantN
G56534FOvaryMucinous adenocarcinoma1T1N0M0IMalignantN
G66640FOvaryMucinous adenocarcinoma2T1aN0M0IAMalignantN
G76734FOvarySerous papillary adenocarcinoma1T1aN0M0IAMalignantN
G86848FOvaryMucinous adenocarcinoma2T1aN0M0IAMalignantN
G96965FOvaryMucinous adenocarcinoma2T2aN0M0IIAMalignantN
G107048FOvaryMucinous adenocarcinoma2T1bN0M0IBMalignantN
H17139FOvaryMucinous adenocarcinoma2T1aN0M0IAMalignantN
H27251FOvaryMucinous adenocarcinoma with degeneration2T1bN0M0IBMalignantN
H37354FOvaryMucinous adenocarcinoma2T2aN0M0IIAMalignantN
H47449FOvaryMucinous adenocarcinoma2T1aN0M0IAMalignantN
H57541FOvaryMucinous adenocarcinoma3T1bN0M0IBMalignantN
H67629FOvaryMucinous adenocarcinoma3T3N0M0IIIMalignantN
H77749FOvaryEndometrioid adenocarcinoma (sparse)2T1N0M0IMalignantN
H87855FOvaryEndometrioid adenocarcinoma2T1N0M0IMalignantN
H97955FOvaryEndometrioid adenocarcinoma with degeneration2T1N0M0IMalignantN
H108050FOvaryClear cell carcinoma*T1N0M0IMalignantN
Tissue Marker
 
 
西安泰博斯生物科技有限公司

 
联系我们
地址：陕西西安市灞桥区长乐东路2999号
电话：029-83533393, 17792711553,
电子邮箱：taibsbio@163.com
QQ:3144647811
微信号：13002913390
邮政编码：710075
关于我们
西安泰博斯生物科技有限公司主要经营组织芯片的研发、销售，加工定制和与组织芯片有关的生物技术服务项目。公司目前拥有专业的病理医生和技术研发团队，并且具有庞大的组织标本库。样本库中组织微阵列种类多，病理类型齐全，同时根据客户需求情况进行制作加工新的组织微阵列，尽量满足每一个客户的需求。公司一直秉承着“认真、严谨、负责”的工作态度，致力于为广大客户提供质量好的产品和优质的服务。

更多详情